Semin intervent Radiol 2022; 39(04): 446-453
DOI: 10.1055/s-0042-1757344

Surbhi B. Trivedi

1   Division of Interventional Radiology, Department of Radiology, the University of Illinois at Chicago, College of Medicine, Chicago, Illinois

,

Charles Ray

1   Division of Interventional Radiology, Department of Radiology, the University of Illinois at Chicago, College of Medicine, Chicago, Illinois

,

Seetharam Chadalavada

2   Division of Interventional Radiology, Department of Radiology, University of Cincinnati, Cincinnati, Ohio

,

Abouelmagd Makramalla

2   Division of Interventional Radiology, Department of Radiology, University of Cincinnati, Cincinnati, Ohio

,

Ali Kord

2   Division of Interventional Radiology, Department of Radiology, University of Cincinnati, Cincinnati, Ohio

› Author Affiliations › Further Information Also available at    Buy Article Permissions and Reprints

Superior vena cava syndrome (SVCS) is a spectrum of symptoms resulting from the obstruction of the easily compressible SVC, due to either external compression from the mediastinal structures or internal narrowing of the vessel. SVCS was first described in 1757 by famed anatomist Sir William Hunter.[1] Malignant causes are the main etiology of SVCS, ranging from 70 to 85% of cases, predominantly due to lung cancer.[2] [3] Historically, infectious conditions such as granulomatous mediastinitis secondary to tuberculosis and syphilitic aortic aneurysm were the predominant causes; however, this has shifted due to antibiotic treatment and increased utility of central venous catheters and endovascular cardiac leads.[4] There is a paucity of guidelines and randomized trials to guide the clinical practice, and SVCS is treated on an individual basis, taking into account the etiology, severity of symptoms, and disease prognosis.[5] Endovascular therapy is considered the first-line treatment for the emergent and benign cases of SVCS, and can be a well-tolerated treatment for long-term symptomatic relief, in conjunction with other therapies.

Publication History

Article published online:
17 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

  References 1 Hunter W. The history of an aneurysm of the aorta with some remarks on aneurysms in general. Med Obs Enq 1757; 1: 323-357 2 Watkinson AF, Yeow TN, Fraser C. Endovascular stenting to treat obstruction of the superior vena cava. BMJ 2008; 336 (7658): 1434-1437 3 Azizi AH, Shafi I, Shah N. et al. Superior vena cava syndrome. JACC Cardiovasc Interv 2020; 13 (24) 2896-2910 4 Lepper PM, Ott SR, Hoppe H. et al. Superior vena cava syndrome in thoracic malignancies. Respir Care 2011; 56 (05) 653-666 5 Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DWN. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus 2016; 5: 229 6 Kapur S, Paik E, Rezaei A, Vu DN. Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction. Radiographics 2010; 30 (01) 67-78 7 Hinton J, Cerra-Franco A, Shiue K. et al. Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report. J Med Case Reports 2018; 12 (01) 301 8 Lanciego C, Pangua C, Chacón JI. et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 2009; 193 (02) 549-558 9 Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome – a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3 (08) 811-814 10 Stanford W, Doty DB. The role of venography and surgery in the management of patients with superior vena cava obstruction. Ann Thorac Surg 1986; 41 (02) 158-163 11 Rossi A, Baravelli M, Cattaneo P. et al. Acute superior vena cava syndrome after insertion of implantable cardioverter defibrillator. J Interv Card Electrophysiol 2008; 23 (03) 247-249 12 Singh AK, Pandey A, Upadhyay S. Superior vena cava syndrome due to pulmonary tuberculosis: a rare presentation. J Assoc Physicians India 2020; 68 (09) 73-74 13 Mínguez C, Roca B, González-Miño C, Simón E. Superior vena cava syndrome during the treatment of pulmonary tuberculosis in an HIV-1 infected patient. J Infect 2000; 40 (02) 187-189 14 Mleyhi S, Sandi T, Ben Mrad M. et al. Tuberculosis lymphadenopathy: a rare etiology of the superior vena cava syndrome. J Med Vasc 2021; 46 (01) 9-12 15 Teo N, Sabharwal T, Rowland E, Curry P, Adam A. Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J 2002; 23 (18) 1465-1470 16 Lickfett L, Bitzen A, Arepally A. et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 2004; 6 (01) 25-31 17 Gilard M, Pérennes A, Mansourati J. et al. Stent implantation for the treatment of superior vena cava syndrome related to pacemaker leads. Europace 2002; 4 (02) 155-158 18 Kim YI, Kim KS, Ko YC. et al. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome. J Korean Med Sci 2004; 19 (04) 519-522 19 Friedman T, Quencer KB, Kishore SA, Winokur RS, Madoff DC. Malignant venous obstruction: superior vena cava syndrome and beyond. Semin Intervent Radiol 2017; 34 (04) 398-408 20 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002; 14 (05) 338-351 21 Ni R, Amr M, Kalla A. Hodgkin lymphoma-associated superior vena cava syndrome: a case report and review of the literature. Am J Case Rep 2021; 22: e929437 22 Ozcan A, Unal E, Karakukcu M, Coskun A, Ozdemir MA, Patiroglu T. Vena cava superior syndrome in the children with mediastinal tumors: single-center experience. North Clin Istanb 2020; 7 (03) 255-259 23 Chan RCL, Chan YC, Cheng SWK. Mid- and long-term follow-up experience in patients with malignant superior vena cava obstruction. Interact Cardiovasc Thorac Surg 2013; 16 (04) 455-458 24 de Gregorio Ariza MA, Gamboa P, Gimeno MJ. et al. Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 2003; 13 (04) 853-862 25 Nagata T, Makutani S, Uchida H. et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 2007; 30 (05) 959-967 26 Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 2009; 64 (02) 174-178 27 Smayra T, Otal P, Chabbert V. et al. Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Intervent Radiol 2001; 24 (06) 388-394 28 Cho Y, Gwon DI, Ko GY. et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?. Korean J Radiol 2014; 15 (01) 87-94 29 Chen B, Lin R, Dai H. et al. Sharp recanalization for treatment of central venous occlusive disease in hemodialysis patients. J Vasc Surg Venous Lymphat Disord 2022; 10 (02) 306-312 30 Keller EJ, Gupta SA, Bondarev S, Sato KT, Vogelzang RL, Resnick SA. Single-center retrospective review of radiofrequency wire recanalization of refractory central venous occlusions. J Vasc Interv Radiol 2018; 29 (11) 1571-1577 31 Guimaraes M, Schonholz C, Hannegan C, Anderson MB, Shi J, Selby Jr B. Radiofrequency wire for the recanalization of central vein occlusions that have failed conventional endovascular techniques. J Vasc Interv Radiol 2012; 23 (08) 1016-1021 32 Fagedet D, Thony F, Timsit JF. et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 2013; 36 (01) 140-149 33 Haddad MM, Simmons B, McPhail IR. et al. Comparison of covered versus uncovered stents for benign superior vena cava (SVC) obstruction. Cardiovasc Intervent Radiol 2018; 41 (05) 712-717 34 Deshwal H, Ghosh S, Magruder K, Bartholomew JR, Montgomery J, Mehta AC. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis. Vasc Med 2020; 25 (02) 174-183 35 Kishi K, Sonomura T, Mitsuzane K. et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993; 189 (02) 531-535